TD Asset Management
BSX icon

TD Asset Management’s Boston Scientific BSX Stock Holding History

TD Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113M Sell
1,799,116
-66,285
-4% -$5.3M 0.09% 181
2025
Q4 		$178M Sell
1,865,401
-129,015
-6% -$12.6M 0.14% 129
2025
Q3 		$195M Sell
1,994,416
-185,778
-9% -$19.2M 0.16% 121
2025
Q2 		$234M Buy
2,180,194
+19,270
+0.9% +$1.95M 0.2% 104
2025
Q1 		$218M Sell
2,160,924
-128,867
-6% -$13M 0.2% 108
2024
Q4 		$205M Buy
2,289,791
+46,255
+2% +$4.07M 0.18% 121
2024
Q3 		$187M Buy
2,243,536
+90,562
+4% +$7.14M 0.17% 133
2024
Q2 		$166M Buy
2,152,974
+93,713
+5% +$6.86M 0.15% 138
2024
Q1 		$141M Buy
2,059,261
+443,329
+27% +$28.5M 0.13% 158
2023
Q4 		$93.4M Buy
1,615,932
+155,565
+11% +$8.3M 0.09% 197
2023
Q3 		$77.1M Buy
1,460,367
+318,058
+28% +$16.7M 0.09% 174
2023
Q2 		$61.8M Buy
1,142,309
+193,329
+20% +$10.1M 0.07% 221
2023
Q1 		$47.5M Buy
948,980
+236,286
+33% +$11.1M 0.06% 262
2022
Q4 		$33M Buy
712,694
+145,321
+26% +$6.29M 0.04% 330
2022
Q3 		$22.3M Buy
567,373
+11,741
+2% +$471K 0.03% 399
2022
Q2 		$20.7M Buy
555,632
+198
+0% +$8.06K 0.02% 425
2022
Q1 		$24.6M Buy
555,434
+2,576
+0.5% +$112K 0.02% 434
2021
Q4 		$23.5M Buy
552,858
+11,643
+2% +$489K 0.02% 476
2021
Q3 		$23.5M Sell
541,215
-6,238
-1% -$276K 0.02% 434
2021
Q2 		$25M Buy
547,453
+23,442
+4% +$986K 0.03% 429
2021
Q1 		$20.3M Sell
524,011
-743
-0.1% -$28.1K 0.02% 459
2020
Q4 		$18.9M Sell
524,754
-859,766
-62% -$31M 0.02% 447
2020
Q3 		$52.9M Sell
1,384,520
-524,152
-27% -$20.2M 0.07% 213
2020
Q2 		$67M Sell
1,908,672
-234,103
-11% -$8.43M 0.1% 172
2020
Q1 		$69.9M Sell
2,142,775
-327,903
-13% -$12.8M 0.12% 148
2019
Q4 		$112M Sell
2,470,678
-404,065
-14% -$16.9M 0.16% 127
2019
Q3 		$117M Sell
2,874,743
-798,996
-22% -$33.9M 0.18% 115
2019
Q2 		$158M Sell
3,673,739
-61,919
-2% -$2.38M 0.24% 83
2019
Q1 		$143M Buy
3,735,658
+148,884
+4% +$5.69M 0.22% 89
2018
Q4 		$127M Sell
3,586,774
-63,476
-2% -$2.3M 0.22% 87
2018
Q3 		$141M Buy
3,650,250
+1,161,994
+47% +$40.6M 0.21% 86
2018
Q2 		$81.4M Buy
2,488,256
+2,094,436
+532% +$63.2M 0.12% 148
2018
Q1 		$10.8M Sell
393,820
-20,721
-5% -$563K 0.02% 506
2017
Q4 		$10.3M Sell
414,541
-14,921
-3% -$412K 0.02% 511
2017
Q3 		$12.5M Sell
429,462
-27,598
-6% -$762K 0.02% 472
2017
Q2 		$12.7M Sell
457,060
-28,596
-6% -$759K 0.02% 470
2017
Q1 		$12.1M Sell
485,656
-300
-0.1% -$7.29K 0.02% 489
2016
Q4 		$10.5M Sell
485,956
-99,802
-17% -$2.18M 0.02% 512
2016
Q3 		$13.9M Sell
585,758
-9,404
-2% -$224K 0.02% 448
2016
Q2 		$13.9M Buy
595,162
+22,090
+4% +$478K 0.03% 433
2016
Q1 		$10.8M Sell
573,072
-33,459
-6% -$588K 0.02% 476
2015
Q4 		$11.2M Buy
606,531
+15,100
+3% +$271K 0.02% 460
2015
Q3 		$9.71M Buy
591,431
+4,500
+0.8% +$76.9K 0.02% 471
2015
Q2 		$10.4M Buy
586,931
+3,370
+0.6% +$60.2K 0.02% 494
2015
Q1 		$10.4M Sell
583,561
-5,479
-0.9% -$86.6K 0.02% 482
2014
Q4 		$7.8M Buy
589,040
+5,359
+0.9% +$68.5K 0.01% 547
2014
Q3 		$6.89M Sell
583,681
-46,021
-7% -$580K 0.01% 562
2014
Q2 		$8.04M Sell
629,702
-36,500
-5% -$475K 0.01% 521
2014
Q1 		$9.01M Sell
666,202
-46,700
-7% -$613K 0.02% 487
2013
Q4 		$8.57M Sell
712,902
-161,600
-18% -$1.91M 0.02% 488
2013
Q3 		$10.3M Buy
874,502
+125,257
+17% +$1.35M 0.02% 424
2013
Q2 		$6.95M Buy
+749,245
New +$6.36M 0.01% 497

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TD Asset Management's BSX Position: Q1 2026 in Review

TD Asset Management reduced its Boston Scientific (BSX) stake by 3.6% in Q1 2026, selling an estimated $5.3M and leaving 1,799,116 shares worth $113M. The position accounts for 0.09% of the portfolio, ranked #181.

TD Asset Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $234M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • TD Asset Management held 1,799,116 shares of Boston Scientific worth $113M as of Q1 2026.
  • TD Asset Management sold 66,285 Boston Scientific shares in Q1 2026, an estimated $5.3M.
  • Boston Scientific made up 0.09% of TD Asset Management's portfolio in Q1 2026, its #181 holding.
  • TD Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • TD Asset Management's Boston Scientific position peaked at $234M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.